SAN

91.5

+0.1%↑

EI

231.3

+0.13%↑

MRK1

137.9

-0.25%↓

SHL.DE

52.04

-0.88%↓

ARGX

606

+1.2%↑

SAN

91.5

+0.1%↑

EI

231.3

+0.13%↑

MRK1

137.9

-0.25%↓

SHL.DE

52.04

-0.88%↓

ARGX

606

+1.2%↑

SAN

91.5

+0.1%↑

EI

231.3

+0.13%↑

MRK1

137.9

-0.25%↓

SHL.DE

52.04

-0.88%↓

ARGX

606

+1.2%↑

SAN

91.5

+0.1%↑

EI

231.3

+0.13%↑

MRK1

137.9

-0.25%↓

SHL.DE

52.04

-0.88%↓

ARGX

606

+1.2%↑

SAN

91.5

+0.1%↑

EI

231.3

+0.13%↑

MRK1

137.9

-0.25%↓

SHL.DE

52.04

-0.88%↓

ARGX

606

+1.2%↑

Search

UCB SA

Cerrado

Sector Salud

185.9 0.68

Resumen

Variación precio

24h

Actual

Mínimo

185.1

Máximo

186.45

Métricas clave

By Trading Economics

Ingresos

104M

Ventas

127M

2.8B

P/B

Media del Sector

78.783

87.008

BPA

2.09

Rentabilidad por dividendo

0.981

Margen de beneficio

3.728

EBITDA

652M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+19.23 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.98%

2.48%

Próximas Ganancias

27 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

778M

35B

Apertura anterior

185.22

Cierre anterior

185.9

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

175 / 392 Clasificación en Healthcare

UCB SA Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

20 dic 2024, 22:40 UTC

Principales Noticias

Rumble Gets $775 Million Investment From Crypto Firm Tether

21 dic 2024, 16:25 UTC

Principales Noticias

House Approves Revised Plan to Avert Government Shutdown -- 6th Update

21 dic 2024, 16:09 UTC

Principales Noticias

House Approves Revised Plan to Avert Government Shutdown -- 4th Update

21 dic 2024, 12:00 UTC

Principales Noticias

America's Chip War With China Will Spread -- Heard on the Street -- WSJ

21 dic 2024, 10:30 UTC

Principales Noticias

H&M's Comeback Plan: Try to Be Cooler -- WSJ

21 dic 2024, 09:20 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

21 dic 2024, 09:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

21 dic 2024, 09:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

21 dic 2024, 05:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

21 dic 2024, 03:51 UTC

Principales Noticias

House Approves Revised Plan to Avert Government Shutdown -- 2nd Update

20 dic 2024, 23:07 UTC

Principales Noticias

House Approves Revised Plan to Avert Government Shutdown -- WSJ

20 dic 2024, 22:24 UTC

Adquisiciones, fusiones, absorciones

Spirit AeroSystems Expects to Complete Sale in Mid-2025

20 dic 2024, 22:23 UTC

Adquisiciones, fusiones, absorciones

Spirit AeroSystems Files Proxy Statement

20 dic 2024, 22:21 UTC

Adquisiciones, fusiones, absorciones

Spirit AeroSystems Holdings to Hold Jan. 31 Stockholder Meeting for Vote on Sale to Boeing

20 dic 2024, 22:08 UTC

Principales Noticias

Republicans to Vote on New Plan to Avert Government Shutdown -- WSJ

20 dic 2024, 21:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

20 dic 2024, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

20 dic 2024, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

20 dic 2024, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

20 dic 2024, 21:41 UTC

Principales Noticias

Stocks Rally on Hopes for More Rate Cuts -- WSJ

20 dic 2024, 21:38 UTC

Adquisiciones, fusiones, absorciones

FedEx Is Breaking Up. Wall Street Loves the Idea. -- Barrons.com

20 dic 2024, 21:32 UTC

Ganancias

These Stocks Moved the Most Today: FedEx, Novo Nordisk, Lilly, Tesla, DJT, Carnival, BlackBerry, U.S. Steel, Sirius XM, and More -- Barrons.com

20 dic 2024, 21:26 UTC

Principales Noticias

U.S. Stock Indexes Rally, but Still End Lower for the Week -- WSJ

20 dic 2024, 21:23 UTC

Ganancias
Acciones populares

Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla -- WSJ

20 dic 2024, 21:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

20 dic 2024, 20:52 UTC

Principales Noticias

Currency Tailspin Forces Brazil's Leader to Do the Unthinkable: Cut Spending -- WSJ

20 dic 2024, 20:27 UTC

Principales Noticias

Volkswagen Aims to Reduce Workforce by 35,000 in Deal With Union -- Update

20 dic 2024, 20:23 UTC

Charlas de Mercado

Crude Prices Rise But Still End Week at a Loss -- Market Talk

20 dic 2024, 20:20 UTC

Principales Noticias

CFPB Sues Big Banks Over Fraud on Zelle -- Barrons.com

20 dic 2024, 20:11 UTC

Charlas de Mercado

Argentine Banks to Face Better Operating Environment in 2025 -- Market Talk

Comparación entre iguales

Cambio de precio

UCB SA Esperado

Precio Objetivo

By TipRanks

19.23% repunte

Estimación a 12 meses

Media 94.86 EUR  19.23%

Máximo 125 EUR

Mínimo 74 EUR

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para UCB SA Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

4

Comprar

1

Mantener

2

Vender

Sentimiento

By Acuity

175 / 392 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

EBITDA

Beneficio operativo

$

Acerca de UCB SA

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.